BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 6358154)

  • 1. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants.
    Shank B; Chu FC; Dinsmore R; Kapoor N; Kirkpatrick D; Teitelbaum H; Reid A; Bonfiglio P; Simpson L; O'Reilly RJ
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1607-11. PubMed ID: 6358154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission.
    Snyder DS; Findley DO; Forman SJ; Nademanee AP; O'Donnell MR; Schmidt GM; Bierman PJ; Fahey JL; Krance RA; Sniecinski IJ
    Blut; 1988 Jul; 57(1):7-13. PubMed ID: 3291991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total body irradiation for bone marrow transplantation: the Memorial Sloan-Kettering Cancer Center experience.
    Shank B; O'Reilly RJ; Cunningham I; Kernan N; Yaholom J; Brochstein J; Castro-Malaspina H; Kutcher GJ; Mohan R; Bonfiglio P
    Radiother Oncol; 1990; 18 Suppl 1():68-81. PubMed ID: 2247651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA; Kernan NA; Groshen S; Cirrincione C; Shank B; Emanuel D; Laver J; O'Reilly RJ
    N Engl J Med; 1987 Dec; 317(26):1618-24. PubMed ID: 3317056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.
    Belkacémi Y; Pène F; Touboul E; Rio B; Leblond V; Gorin NC; Laugier A; Gemici C; Housset M; Ozsahin M
    Strahlenther Onkol; 1998 Feb; 174(2):92-104. PubMed ID: 9487372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation.
    Frassoni F; Scarpati D; Bacigalupo A; Vitale V; Corvo R; Miceli S; Gualandi F; Occhini D; Clavio M; van Lint MT
    Br J Haematol; 1989 Oct; 73(2):211-6. PubMed ID: 2684259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team).
    Woods WG; Nesbit ME; Ramsay NK; Krivit W; Kim TH; Goldman A; McGlave PB; Kersey JH
    Blood; 1983 Jun; 61(6):1182-9. PubMed ID: 6340756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group.
    Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
    Blood; 1995 Mar; 85(5):1391-5. PubMed ID: 7858269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
    Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
    Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
    Van der Jagt RH; Appelbaum FR; Petersen FB; Bigelow CL; Fisher LD; Schoch GH; Buckner CD; Sanders JE; Storb R; Sullivan KM
    Bone Marrow Transplant; 1991 Sep; 8(3):211-5. PubMed ID: 1958901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
    Bacigalupo A; Vitale V; Corvò R; Barra S; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Raiola AM; Van Lint MT; Frassoni F
    Br J Haematol; 2000 Jan; 108(1):99-104. PubMed ID: 10651732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant.
    Lawton CA; Barber-Derus S; Murray KJ; Casper JT; Ash RC; Gillin MT; Wilson JF
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):319-22. PubMed ID: 2666364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
    Bordigoni P; Vernant JP; Souillet G; Philippe N; Maraninchi D
    Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation (BMT) for acute nonlymphoid leukemia (ANLL) in first remission.
    Bacigalupo A; Frassoni F; Van Lint MT; Pittaluga PA; Piaggio G; Repetto M; Congiu M; Vitale V; Scarpati D; Corvò R
    Acta Haematol; 1985; 74(1):23-6. PubMed ID: 3934903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.
    Coccia PF; Strandjord SE; Warkentin PI; Cheung NK; Gordon EM; Novak LJ; Shina DC; Herzig RH
    Blood; 1988 Apr; 71(4):888-93. PubMed ID: 3281725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
    Riddell S; Appelbaum FR; Buckner CD; Stewart P; Clift R; Sanders J; Storb R; Sullivan K; Thomas ED
    J Clin Oncol; 1988 Apr; 6(4):576-82. PubMed ID: 3282031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of leukaemic marrow and prevention of leukaemia relapse with total body irradiation and bone marrow transplantation.
    Frassoni F
    Med Oncol Tumor Pharmacother; 1991; 8(3):189-201. PubMed ID: 1803180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.